Peter G. Traber's Insider Trades & SAST Disclosures
Peter G. Traber's most recent trade in Selecta Biosciences Inc was a trade of 8,164 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Jan. 4, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Peter G. Traber.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 8,164 | 449,601 (0%) | 0% | 1.1 | 9,256 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 3,445 | 446,141 (0%) | 0% | 1.1 | 3,890 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 04 Jan 2023 | 20 | 446,121 (0%) | 0% | 1.1 | 22 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 15 | 449,586 (0%) | 0% | 1.1 | 17 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 900,000 | 900,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 200,000 | 457,765 (0%) | 0% | 0 | Common Stock | |
| Lisata Therapeutics Inc | Peter G. Traber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 65,430 | 149,190 (1%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.09 per share. | 05 Jan 2022 | 3,226 | 251,355 (0%) | 0% | 3.1 | 9,955 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 415,900 | 415,900 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 90,200 | 254,581 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 10 Dec 2021 | 4,083 | 164,381 (0%) | 0% | 3.0 | 12,196 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 13,750 | 168,464 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 13 Oct 2021 | 3,636 | 154,714 (0%) | 0% | 4.4 | 15,962 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 13,750 | 158,350 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2021 | 54,400 | 54,400 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2021 | 9,100 | 144,600 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 26 May 2021 | 20,000 | 135,500 (0%) | 0% | 4.0 | 79,850 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.32 per share. | 24 May 2021 | 12,500 | 110,500 (0%) | 0% | 3.3 | 41,498 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.48 per share. | 24 May 2021 | 5,000 | 115,500 (0%) | 0% | 3.5 | 17,400 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 17 Mar 2021 | 10,000 | 98,000 (0%) | 0% | 4.5 | 45,000 | Common Stock |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.53 per share. | 17 Mar 2021 | 10,000 | 88,000 (0%) | 0% | 4.5 | 45,295 | Common Stock |
| Lisata Therapeutics Inc | Peter G. Traber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 37,735 | 83,760 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 230,000 | 230,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Peter G. Traber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 38,000 | 78,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges